Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Depreciation and Depletion (2018 - 2023)

Viemed Healthcare's Depreciation and Depletion history spans 6 years, with the latest figure at $6.0 million for Q3 2023.

  • For Q3 2023, Depreciation and Depletion rose 44.99% year-over-year to $6.0 million; the TTM value through Sep 2023 reached $20.3 million, up 41.31%, while the annual FY2022 figure was $15.6 million, 38.17% up from the prior year.
  • Depreciation and Depletion reached $6.0 million in Q3 2023 per VMD's latest filing, up from $5.2 million in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $6.0 million in Q3 2023 to a low of $1.3 million in Q2 2019.
  • Average Depreciation and Depletion over 5 years is $3.1 million, with a median of $2.8 million recorded in 2020.
  • Peak YoY movement for Depreciation and Depletion: soared 70.68% in 2019, then grew 9.98% in 2021.
  • A 5-year view of Depreciation and Depletion shows it stood at $2.0 million in 2019, then soared by 41.71% to $2.8 million in 2020, then increased by 9.98% to $3.1 million in 2021, then soared by 40.16% to $4.4 million in 2022, then soared by 36.63% to $6.0 million in 2023.
  • Per Business Quant, the three most recent readings for VMD's Depreciation and Depletion are $6.0 million (Q3 2023), $5.2 million (Q2 2023), and $4.8 million (Q1 2023).